Lancet HIV, 8(2), e96-e105. ELSEVIER SCIENCE INC ATHENA observational cohort 2021, ' HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals : a retrospective cohort study ', The Lancet HIV, vol. 8, no. 2, pp. e96-e105 . https://doi.org/10.1016/S2352-3018(20)30301-5 Lancet HIV, 8(2), e96-e105. Elsevier Limited The Lancet HIV, 8, 2, pp. e96-e105 The Lancet HIV, 8(2), e96-e105. Elsevier Limited The Lancet HIV, 8(2), e96-e105. Elsevier Ltd. The Lancet HIV, 8, e96-e105 The Lancet HIV, 8(2), E96-E105. ELSEVIER INC
Journal of Infection, 74(4), 393-400. W.B. Saunders Ltd Journal of infection, 74(4), 393-400. W.B. Saunders Ltd Journal of Infection, 74(4), 393-400. Elsevier Saunders The Journal of Infection, 74(4), 393. W.B. Saunders Ltd Woestenberg, P J, King, A J, van der Sande, M A B, Donken, R, Leussink, S, van der Klis, F R M, Hoebe, C J P A, Bogaards, J A, van Benthem, B H B, Medical Microbiological Laboratories & Public Health Services 2017, ' No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors ', Journal of Infection, vol. 74, no. 4, pp. 393-400 . https://doi.org/10.1016/j.jinf.2017.01.007
BMC Infectious Diseases, 16, 1, pp. 140 BMC infectious diseases, 16(1). BioMed Central BMC Infectious Diseases, 16(1):140. BioMed Central BMC Infectious Diseases, 16, 140 BMC Infectious Diseases Leeflang, M M G, Ang, C W, Berkhout, J, Bijlmer, H A, Van Bortel, W, Brandenburg, A H, Van Burgel, N D, Van Dam, A P, Dessau, R B, Fingerle, V, Hovius, J W R, Jaulhac, B, Meijer, B, Van Pelt, W, Schellekens, J F P, Spijker, R, Stelma, F F, Stanek, G, Verduyn-Lunel, F, Zeller, H & Sprong, H 2016, ' The diagnostic accuracy of serological tests for Lyme borreliosis in Europe : A systematic review and meta-analysis ', BMC Infectious Diseases, vol. 16, no. 1, 140 . https://doi.org/10.1186/s12879-016-1468-4